Sponsor & Developer Portfolio
Instituto Nacional de Salud Publica, Mexi
Clinical development pipeline, platform architecture, and registered trial tracking for Instituto Nacional de Salud Publica, Mexi vaccine candidates.
1
Candidates
1
Target Diseases
1
Linked Studies
Development Phase Distribution
Discontinued / Inactive: 1
Platform Technologies
Biological (unspecified platform): 1
Target Pathogens & Indications
Influenza
Vaccine Pipeline Candidates (1)
Detailed candidate profiles, clinical phases, target indications, and anticipated milestones.
Discontinued / Inactive
ctgov-vaccine-sanofi-a-h1n1-15-ug-trivalent-instituto-nacional-de-salu
Vaccine Sanofi A(H1N1) 7.5 ug
Target: Influenza
Platform: Biological (unspecified platform)
Key Milestone: Primary completion (most advanced trial): 2010-06 (registry estimate)
Explore Other Vaccine Developers & Sponsors
Compare pipeline volume, phase progression, and modalities across global biopharmaceutical manufacturers.